← SynDRA
PRINOMASTAT
SynDRA canonical compound SYN0003217 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | MMP1 | MMP2 | MMP3 | MMP9 |
|---|
| Mechanism of action | matrix metalloprotease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- matrix metalloprotease inhibitor
- MMP2 INHIBITOR
- MMP1 INHIBITOR
- MMP7 INHIBITOR
Drug classes
- Matrix Metalloproteinase Inhibitors
Cross-references
Synonyms
- AG-3340
- AG3340
- KB-R-9896
- AG-3354
- AG-3362
- Prinomastat (USAN/INN)
- (3S)-N-hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylthiomorpholine-3-carboxamide
- AG 3340
- prinomastatum
- KB-R 9896
- CHEBI:138885
- RefChem:868518
- DTXCID1023946
- Prinomastat [USAN:INN]
- UNII-10T6626FRK
- AG3340;KB-R9896
- PN0
- PRINOMASTAT [MI]
- PRINOMASTAT [INN]
- PRINOMASTAT [USAN]
- PRINOMASTAT [WHO-DD]
- SCHEMBL115696
- GTPL6505
- orb1708811
- GLXC-15454
- SHA32942
- BDBM50082556
- EBC-46165
- AKOS000280753
- CS-7961
- T12539L
- NCGC00485069-01
- NCGC00485069-02
- HY-12170
- MS-27439
- NS00068314
- D03797
- G13508
- EN300-7503678
Look up PRINOMASTAT in the interactive SynDRA portal →